Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from caPSURE

Urology

Volumn 53, Issue 1, 1999, Pages 180-186

  Lubeck, Deborah P ^a,b   Litwin, Mark S ^c   Henning, James M ^d   Stoddard, Marcia L ^a   Flanders, Scott C ^d   Carroll, Peter R ^b  

^a Lewin TAG Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TAP Holdings Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; OBSERVATION; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; SCORING SYSTEM;

AGED; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0032958078     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00408-7     Document Type: Article

References (24)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1998. CA Cancer J Clin. 48:1998;6-29.
2. Gittes R.F. Carcinoma of the prostate. N Engl J Med. 324:1991;236-245.
3. Perez C.A., Fair W.R., Ihde D.C. Carcinoma of the prostate. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer Principles and Practice of Oncology . 3rd ed. 1989;1023-1058 JB Lippincott, Philadelphia.
4. Bagshaw MA, Cox RS, and Ray GR: Status of radiation treatment of prostate cancer at Stanford University, in NCI Monographs No. 7. Washington, Government Printing Office (NIH Publ. No. 88-3005), 1988, pp 127-131.
5. Beard C.J., Propert K.J., Rieker P.P., et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients a prospective multi-institutional outcomes study . J Clin Oncol. 15:1997;223-229.
6. Talcott J.A., Rieker P., Propert K.J., et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 89:1997;1117-1123.
7. Auchincloss S.S. Sexual dysfunction in cancer patients issues in evaluation and treatment . Holland J.C., Rowland J.H. Handbook of Psychooncology. 1989;383-413 Oxford University Press, New York.
8. Herr J.W. Strategies for the management of recurrent and advanced urologic cancers quality of life . Cancer. 60:(3 suppl):1987;623-630.
9. Ofman U.S., Auchincloss S.S. Sexual dysfunction in cancer patients. Curr Opin Oncol. 4:1992;606-613.
10. Singer P.A., Tasch E.S., Stocking C., et al. Sex or survival trade-offs between quality and quantity of life . J Clin Oncol. 9:1991;238-244.
11. DaSilva F.C., Reis E., Costa T., et al. Quality of life in patients with prostatic cancer. Cancer. 71:1993;1138-1142.
12. Quality of life and treatment of hormone resistance metastatic prostatic cancer. Eur J Cancer. 26:1990;1133-1136.
13. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
14. Fowler F.J., Barry M.J., Lu-Yao G., et al. Patient-reported complications and follow-up treatment after radical prostatectomy The national Medicare experience: 1988-1990 (updated June 1993) . Urology. 42:1993;622-629.
15. Lim A.J., Brandon A.H., Fiedler J., et al. Quality of life radical prostatectomy versus radiation therapy for prostate cancer . J Urol. 154:1995;1420-1425.
16. Shrader-Bogen C.L., Kjellberg J.L., McPherson C.P., et al. Quality of life and treatment outcomes. Cancer. 79:1997;1977-1986.
17. Albertsen P.C., Aaronson N.K., Muller M.J., et al. Health-related quality of life among patients with metastatic prostate cancer. Urology. 2:1997;207-217.
18. Litwin M.S., Hays R.D., Fink A., et al. The UCLA prostate cancer index development, reliability, and validity of a health-related quality of life measure . Med Care. 36:1998;1002-1012.
19. Stewart A.L., Greenfield S., Hays R.D. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 262:1989;907-913.
20. Lubeck D.P., Litwin M.S., Henning J.H., et al. Measurement of health-related quality of life in men with prostate cancer data from the CaPSURE™ database . Qual Life Res. 6:1997;385-392.
21. The CaPSURE database a methodology for clinical practice and research in prostate cancer . Urology. 48:1996;773-777.
22. Ware J.E. SF-36 Health Survey Manual and Interpretation Guide . 2nd ed. 1997;The Health Institute, Boston.
23. Herr H., Kornblith A.B., Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer. 71:1993;1143-1147.
24. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates results of the Massachusetts male aging study . J Urol. 151:1994;54-61.